Recipharm announced on Feb. 18, 2022 that it has acquired Vibalogics and Arranta Bio, both contract development and manufacturing organizations (CDMOs), expanding its manufacturing capabilities in the virotherapy and advanced therapy spaces, respectively. Source: Biopharm International 21/2/22